Total Funding
29
2
Total FundingGrant raised
Growth Score 29 in past quarter
-3 pts
Heat Score 2 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2711405
Acura Pharmaceuticals develops and commercializes tamper-resistant products for medication abuse and misuse.
- Robert B. Jones: CEO
About the Company
Acura Pharmaceuticals, is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse. The Centers for Disease Control and Prevention estimates that one person dies every 19 minutes from prescription drug abuse in the United States. For nearly a decade, Acura has been at the
forefront of developing solutions to combat this epidemic, with products utilizing the Company’s proprietary abuse-deterrent AVERSION® and IMPEDE® Technologies.